Origin, maintenance and spread of antibiotic resistance genes within plasmids and chromosomes of bloodstream isolates of Escherichia coli by Goswami, Cosmika et al.
1Origin, maintenance and spread of antibiotic resistance genes 
within plasmids and chromosomes of bloodstream isolates of 
Escherichia coli
Cosmika Goswami1, Stephen Fox1, Matthew T.G. Holden2, Martin Connor3, Alistair Leanord1 and Thomas J. Evans1,*
RESEARCH ARTICLE
Goswami et al., Microbial Genomics 2020;6
DOI 10.1099/mgen.0.000353
Received 15 September 2019; Accepted 24 February 2020; Published 11 March 2020
Author affiliations: 1Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK; 2School of Medicine, University of St. 
Andrews, UK; 3Dumfries and Galloway Royal Infirmary, Dumfries, UK.
*Correspondence: Thomas J. Evans,  tom. evans@ glasgow. ac. uk
Keywords: bacteremia; extended spectrum beta- lactamases; horizontal gene transfer.
Abbreviations: ABR, antibioitc resistance; CALIN, clusters of attC sites lacking intergon- integrases; E. coli, Escherichia coli; ENA, European Nucelotide 
Archive; ESBL, extended spectrum beta- lactamase; ST, sequence type.
All genome data for this study have been deposited in European Nucleotide Archive (ENA). Short read Illumina sequences were deposited under 
accession PRJEB12513. The raw FAST5 PacBio sequences and Unicycler assemblies were submitted under the project accession PRJEB33761.
Data statement: All supporting data, code and protocols have been provided within the article or through supplementary data files. Three supplementary 
tables and three supplementary figures are available with the online version of this article.
000353 © 2020 The Authors
This is an open- access article distributed under the terms of the Creative Commons Attribution License.
Abstract
Blood stream invasion by Escherichia coli is the commonest cause of bacteremia in the UK and elsewhere with an attributable 
mortality of about 15–20 %; antibiotic resistance to multiple agents is common in this microbe and is associated with worse 
outcomes. Genes conferring antimicrobial resistance, and their frequent location on horizontally transferred genetic elements 
is well- recognised, but the origin of these determinants, and their ability to be maintained and spread within clinically- relevant 
bacterial populations is unclear. Here, we set out to examine the distribution of antimicrobial resistance genes in chromosomes 
and plasmids of 16 bloodstream isolates of E. coli from patients within Scotland, and how these genes are maintained and 
spread. Using a combination of short and long- read whole genome sequencing methods, we were able to assemble complete 
sequences of 44 plasmids, with 16 Inc group F and 20 col plasmids; antibiotic resistance genes located almost exclusively within 
the F group. bla
CTX- M15
 genes had re- arranged in some strains into the chromosome alone (five strains), while others contained 
plasmid copies alone (two strains). Integrons containing multiple antibiotic genes were widespread in plasmids, notably many 
with a dfrA7 gene encoding resistance to trimethoprim, thus linking trimethoprim resistance to the other antibiotic resistance 
genes within the plasmids. This will allow even narrow spectrum antibiotics such as trimethoprim to act as a selective agent 
for plasmids containing antibiotic resistance genes mediating much broader resistance, including blaC
TX- M15
. To our knowledge, 
this is the first analysis to provide complete sequence data of chromosomes and plasmids in a collection of pathogenic human 
bloodstream isolates of E. coli. Our findings reveal the interplay between plasmids and integrative and conjugative elements in 
the maintenance and spread of antibiotic resistance genes within pathogenic E. coli.
DATA SummARy
All genome data for this study have been deposited in 
European Nucleotide Archive (ENA). Short- read Illumina 
sequences were deposited under accession PRJEB12513. The 
raw FAST5 PacBio sequences and Unicycler assemblies were 
submitted under the project accession PRJEB33761. The 
global ST69 isolates with their accession details are in Table 
S1, (available in the online version of this article).
InTRoDuCTIon
Resistance to antimicrobial drugs is now widespread in many 
bacteria, associated with a poorer outcome from infection 
and increased costs to healthcare systems [1, 2]. In the USA, 
antibiotic resistant organisms in 2014 were estimated to cause 
over two million infections and 23 000 deaths [3], while esti-
mates in Europe from 2015 reported 33 000 deaths from such 
infections, about 75 % of which were healthcare- associated 
[4]. A report in 2015 chaired by Jim O’Neil estimated that 
between 2014–2050 the world economy would lose up to 
100 trillion US dollars of economic output if the spread of 
antimicrobial resistance is not checked [5].
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Bloodstream invasion by bacteria represents one of the most 
severe consequences of infection, the commonest isolate 
being the Gram- negative pathogen Escherichia coli, respon-
sible for about one- third of such infections worldwide [6], and 
showing a steady increase in incidence over the last 10 years 
[7–9]. Antibiotic resistance in these isolates is widespread and 
rising. Of particular concern is the rise in incidence of E. coli 
expressing extended spectrum β-lactamases (ESBL) which 
produce resistance to 3rd generation cephalosporins - in 
England in 2017 13 % of bloodstream isolates of E. coli were 
resistant to 3rd generation cephalosporins [10], while within 
Europe the rate was 14.9 % [11]. Similar rates are reported 
from the USA [12]. Thirty day mortality from bloodstream E. 
coli infections is reported to be about 10–20 % in a number of 
studies [13–15]. Such infections with ESBL- producing E. coli 
have a worse prognosis [16], particularly if initial therapy is 
with a third- generation cephalosporin [17]. Rates of resist-
ance to other commonly broad- spectrum antibiotics are also 
common in E. coli, and frequently co- exist; in the European 
Union in 2017, 6.3 % of E. coli isolates had combined resist-
ance to fluoroquinolones, third- generation cephalosporins 
and aminoglycosides.
The genetic basis of antibiotic resistance is generally well 
understood. For example, ESBLs are encoded by a number of 
genes [18], but those of the CTX- M class are some of the most 
widespread and increasing in incidence [19]. In particular, the 
CTX- M15 variant is common and geographically widespread 
[20], particularly in the epidemic ST131 lineage [21]. blaCTX- M 
and other antibiotic- resistance encoding genes are frequently 
found on plasmids [22]. These autonomously replicating 
genetic elements can spread through vertical transmission 
of parent to offspring, but also by horizontal transmission 
through bacterial conjugation [23]. Plasmids will place a 
potential selection burden on the cells in which they exist, 
since replication and translation of plasmid genes will have a 
negative fitness cost [24]. Thus, antibiotic usage will provide 
a selective pressure for plasmid maintenance. However, plas-
mids can survive even in the absence of antibiotic selection, 
through other mechanisms such as post- segregational killing 
systems that encode a stable toxin and labile anti- toxin [25], as 
well as co- evolutionary adaptations in host chromosome and 
plasmid that reduce fitness costs [26]. Moreover, antibiotic 
resistance genes can be mobilised from plasmid to chromo-
some, removing the need for continued antibiotic presence 
for maintenance [27]. Such genetic mobility also allows plas-
mids from different microbes to recombine, producing novel 
plasmids, as well as acquiring new antibiotic- resistance genes.
Horizontal gene transfer and the other factors described in 
the previous paragraph contribute to the complexity of anti-
microbial resistance. Transfer of antibiotic- resistance genes 
between microbes may increase their spread in pathogenic 
bacteria. Transfer of these genes from bacteria in farm and 
other animals may also be significant [28]. Strict control 
of antibiotic usage has limited the prevalence of some 
antibiotic- resistant genes, but is not universally the case 
[29]. Use of narrow- spectrum agents might also limit the 
generation of resistance to broader spectrum agents, although 
genetic linkage of determinants of resistance might lead to 
inadvertent co- selection of resistance to both. Moreover, 
experimental studies have shown that acquisition of multiple 
antibiotic resistance genes can offset the fitness cost of either, a 
genetic interaction known as reciprocal sign epistasis [26, 30]. 
To what extent these mechanisms are operative in natural 
communities of pathogenic E. coli causing disease in humans 
is not clear.
In order better to understand the origin, maintenance and 
spread of antimicrobial resistance determinants within 
human pathogenic bacteria, we have undertaken a detailed 
genetic analysis of bloodstream isolates of E. coli from patients 
in Scotland [31]. In this study, we have combined short and 
long- read genome sequencing of 16 E. coli bloodstream 
isolates of the common ST131 and ST69 lineages to recon-
struct the complete chromosomal and plasmid structure of 
these microbes. A total of 46 plasmids were reconstructed 
and antibiotic resistance genes in these elements and the 
corresponding bacterial chromosome analysed. The plasmids 
were highly heterogeneous with evidence of large amounts of 
rearrangement by horizontal transfer, both from other E.coli 
strains as well as other Enterobacteriacae. blaCTX- M15 genes 
had re- arranged in some strains into the chromosome alone 
(five strains), while others contained plasmid copies alone 
Impact Statement
Autonomously replicating plasmids are important 
elements determining bacterial resistance to a number 
of antimicrobial agents. Understanding the origin of 
these elements, and how they are maintained and 
spread, is thus crucial in tackling the alarming rise in 
bacterial antimicrobial resistance. In this paper, we have 
fully sequenced chromosomes and plasmids from blood-
stream isolates of Escherichia coli, the commonest cause 
of bloodstream infection worldwide. Our results iden-
tify how antimicrobial resistance genes can be spread 
by plasmids through a number of mechanisms: direct 
plasmid transfer by conjugation; horizontal transmission 
into other plasmids; and transfer into the host chromo-
some. These results are of broad significance in the fields 
of bacterial genomics, plasmid biology and antimicrobial 
resistance. The results advance our knowledge of how 
plasmids can survive within bacterial hosts that have 
the ability to produce bloodstream invasion, and how 
they can spread antimicrobial resistance genes to other 
bacterial strains. We demonstrate linkage of different 
antimicrobial resistance genes on plasmids, which will 
allow co- selection of genes mediating very broad anti-
biotic resistance even when using a narrow- spectrum 
agent. Targeting plasmid- mediated antimicrobial resist-
ance thus presents a significant challenge; our results 
provide a better understanding of how such plasmid- 
mediated resistance might be tackled in the future.
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(two strains). Integrons containing multiple antibiotic genes 
were widespread in plasmids, notably many with a DfrA7 
gene encoding resistance to trimethoprim, thus linking 
trimethoprim resistance to the other antibiotic resistance 
genes within the plasmids. Our findings show the impact of 
horizontal spread of antibiotic resistance genes, and mecha-
nisms allowing spread and transmission.
mETHoDS
Assembly of sequences
DNA was extracted for short- read Illumina sequencing of 162 
genomes at the Wellcome Sanger Centre, UK as described 
in Goswami et al. [31]. For long- read sequencing 16 strains 
were selected based on higher numbers of ABR genes and 
plasmid replicons, and was conducted using PacBio SMRT 
sequencing at the Norwegian Sequencing Centre, University 
of Oslo, Norway. Two 8- sample multiplex libraries (8- plex) 
were created and run on separate SMRT cells (PacBio RS2). 
High quality finished genomes for these 16 genomes were 
constructed, using both long and short- reads, by hybrid 
assembly method of UniCycler v4.0.0 (31) under normal 
mode of assembly, keeping other settings as default. The 
assembled circular genomes and circular plasmids were then 
annotated with Prokka v1.11 [32].
Phylogenetic tree construction
Using the Prokka- annotated genomes, the pan- genomes were 
investigated for protein clustering using Roary [33] (>95 % 
amino acid identity). The 44 completed circular plasmid 
sequences were then extracted and a gene phylogenetic ML 
tree [34] was built to look into the gene similarity within the 
plasmids.
Antibiotic gene and Toxin/Antitoxin pair 
identification
SRST2 [35] was used on short- reads to determine ABR gene 
from ARG- Annot database [36], virulence determinants from 
VirulenceFinder [37] database and plasmid replicon genes 
from PlasmidFinder [38] database. For identification of 
these genes in the hybrid assembled contigs, BLASTn (>90 % 
coverage and >90 % identity) search was performed against 
them. An inhouse curated database was used for toxin- 
antitoxin gene identification. Comparison of sequences was 
done using Artemis genome visualization [39] and EasyFig 
[40].
Integron identification
IntegronFinder [41] identified the Class I integron cassettes 
and the CALIN cassettes within the assemblies with a 
maximum threshold for the attC sites as 200 bp and a 
minimum as 40 bp.
Global ST69 comparisons
An additional 328 ST69 isolates were collected from Enter-
obase v1.1.2; these are listed with their accession numbers in 
Table S1. The E. coli strain UMN026 (Accession NC_011751.1) 
was used as the reference genome to map all 328 short- read 
sequences (including 11 isolates from Scotland). The variants 
were then identified using VarScan [42] and recombination 
regions were filtered by Gubbins [43]. The midpoint rooted 
SNP based phylogenetic tree was built using RAxML [34]. De 
novo assembly of the short- read sequences was performed 
using SPAdes v3.8.1 [44] assembler. To identify plasmid 
homologous regions within these short- read sequences, 
p1ESCUM (Accession CU928148.1, 122 301 bp long) plasmid 
was divided into six contiguous segments based on its homo-
geneity (>97 % identity) with complete IncF plasmids (Fig. 4). 
These six segments were blasted (for >90 % identity threshold) 
against the de novo assembled contigs for percentage of 
coverage of those regions within 328 isolates. The coverage 
of three gene cassettes (Class I integron, strA- B module and 
mer module) were also calculated using BLASTn.
Conjugation
Bacterial conjugation was performed as described by Johnson 
et al. [45]. Briefly, two donor strains (EC0_10 and EC1_72) 
and a recipient strain, resistant to rifampicin (DH10B), 
were grown overnight LB broth without antibiotics. Strains 
were diluted 1 : 100 in fresh LB and grown for 4 h. Donor 
and recipient strains were mixed at a ratio of 1 : 10, respec-
tively, and incubated for 18 h without shaking at 37 ˚ C. The 
cultures were heavily vortexed before serial dilutions and 
plating onto LB agar containing; ampicillin (100 µg ml−1) or 
cefotaxime (1 µg ml−1) for donor selection, with and without 
rifampicin (100 µg ml−1), for recipient background selection. 
The strain conjugation combinations were performed in 
triplicate. Transconjugant and donor colony forming units 
were determined by serial dilutions and results are expressed 
as transconjugants per donor cell input. The lower limit of 
detection was 10−8 transconjugants per donor cell; conjuga-
tions were repeated three times.
mahalanobis distance determination
Mahalanobis distances of the plasmids from their corre-
sponding chromosomes were calculated using the method 
described by Suzuki et al. [46] and inhouse scripts in R 
v3.5.3. First, the dinucleotide relative frequencies of the 
chromosomes were calculated, with a moving window of 
5 kb length, along the length of each chromosome as well as 
plasmids. These frequencies were then used to calculate the 
value of D2 using function ‘Mahalanobis’ under R package 
stats. This metric is a measure of the similarity between the 
sequences of plasmids and their hosts, and has been shown 
to be a reliable indicator of the similarity of plasmids to 
their long term hosts. The absolute value of the Mahalanobis 
distance is difficult to interpret as its upper limit is bound-
less; a more useful comparator is a derived p value which 
is the probability of the observed value of the Mahalanobis 
value falling within the empirical distribution of Mahalanobis 
values for 5 kb segments of the bacterial chromosome. A value 
approaching one shows high similarity between plasmid and 
chromosome, a low value the converse. The empirical p values 
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were evaluated as frequency of number of plasmid fragments 
that are greater than the mean distance of a plasmid from its 
corresponding chromosome. Similar dinucleotide composi-
tions between a plasmid and chromosome gives a p- value 
close to one whereas p- values close to zero indicate large 
distances and dissimilar dinucleotide compositions between 
a plasmid and chromosome.
RESuLTS
Selection of bloodstream isolates of E. coli for 
plasmid and chromosomal sequencing
We have recently analysed 162 bloodstream isolates from 
patients within Scotland in the years 2013–2015 [31]. The 
two commonest sequence types (ST) were ST131 and ST69 
comprising 24 and 16% respectively of the total isolates. 
ST131 was predominantly isolated in healthcare- associated 
infection while ST69 was more associated with community- 
acquired cases [31]. We picked 16 of these isolates for further 
sequencing using single molecule real time sequencing, 12 
ST131 and four ST69 isolates. These isolates were chosen 
based on being representative of the dominant ST popula-
tions, and contained a variety of antimicrobial resistance 
determinants. We selected isolates that short- read sequences 
indicated contained the gene for CTX- M15, the main 
extended spectrum β-lactamase in this collection, and a range 
of plasmid replicons as identified from short- read sequences. 
In ST131 and ST69, IncF replicons were present in >95 % 
of the strains from this collection [31]. This is only a small 
sample from the whole sequenced collection of bloodstream 
isolates, but we felt would provide insights into the origin, 
spread and persistence of antimicrobial resistance genes in 
representative examples of the E. coli bloodstream isolates. 
A maximum likelihood phylogenetic tree based on the core 
genomes of these isolates is shown in Fig. S1 together with 
their content of antimicrobial resistance genes identified from 
short- read sequencing. This shows the close genetic relation-
ship as expected between the isolates from the same ST group.
We were able to complete plasmid assemblies for 46 plasmids 
from these isolates by combining the short (Illumina) and 
long- reads (PacBio) using the Unicycler pipeline [47]; the 
details of the isolates and plasmids are shown in Table 1. The 
identified source of the infection was classed as urine for eight 
of the 16 isolates. Seven of the isolates were resistant to cefo-
taxime and thus suspected to harbour an ESBL. For the isolate 
ECO_56, Unicycler was unable to bridge completely two IncF 
plasmids: ECO_56_C3 and ECO_56_C4. The contigs from 
these assemblies are very accurate but they have been omitted 
from some of the analyses where indicated.
Phylogenetic tree of plasmid accessory genome, 
replicon types and antibiotic resistance genes
Analysis of the gene content of all the 46 fully reconstructed 
plasmids revealed a total of 916 genes, 133 of these being shell 
genes (found in >15 % but <95 % of plasmids); the remaining 
783 genes were cloud genes (found in <15 % of plasmids). 
There were no core genes. Inc F plasmids had the highest 
percentage of cloud genes (50.0 % of total genes); col and 
others were much lower (16.7 and 1.24% respectively; Table 
S2). A phylogenetic tree based on the accessory genome of 
the plasmids is shown in Fig. 1, together with the replicon 
types of the plasmids, antibiotic resistance genes, and toxin/
antitoxin pairs. Comparison of the different plasmid groups 
shows that the IncF plasmids were more divergent than 
the col- type plasmids. Broadly the plasmids fell into three 
replicon groups: IncF, col- type and others. The larger IncF 
group plasmids were more diverse than the col plasmids. Plas-
mids within the IncF group showed multiple F replicons, a 
feature previously noted using hybridisation assays [48]; three 
IncF group plasmids also contained IncQ replicon sequences. 
Whether these different replicons are all functionally active 
remains to be shown. However, it is notable that of the 16 
IncF plasmids, four have four IncF origins, seven have three, 
two have two, and three just one. This bias towards multiple 
IncF replicons suggests a positive selection pressure favouring 
such multiple replicons. This would tend to restrict entry of 
other IncF plasmids because of plasmid incompatibility and 
thus a means of these IncF plasmids from preventing entry 
of other IncF plasmids into the same bacterial cell. Indeed, 
all but one (EC1_72) of our sequenced strains contained just 
one IncF plasmid; EC1_72 contains two IncF plasmids, with 
different replicons. In contrast, plasmids with col replicons 
typically have only one replicon; of 20 exclusively col replicon 
containing plasmids, 15 have just one replicon, a significantly 
different distribution from the IncF plasmids (P<0.001, Chi- 
squared test).
The presence of antibiotic resistance genes within these plas-
mids is also shown in Fig. 1. Resistance genes were present 
almost exclusively within the IncF group; one plasmid of 
unknown incompatibility group did contain some resist-
ance genes (ECO_56_C5). No col- type plasmids contained 
antibiotic resistance genes. Also shown in Fig. 1 is the pres-
ence of toxin/antitoxin pairs important as part of plasmid 
maintenance through postsegregational killing mechanisms 
[49]. Again, these are restricted almost exclusively to the IncF 
plasmid group.
IncF Plasmids
As the antibiotic resistance genes resided almost exclusively 
within the IncF plasmid group, we analysed these in more 
detail. A detailed phylogenetic tree of these plasmids and 
the regions of similarity is shown in Fig. 2a. Five of these 
plasmids showed significant overall homology: ECO_73_C3, 
EC1_36_C2, EC1_5_C2 (all from ST69) and ECO_42_C2 and 
EC1_77_C2 (both ST131). The remainder showed consider-
able differences, although with obvious elements of homology, 
and with marked rearrangements.
Distribution of Integrons within IncF Plasmids
Given the importance of integrons in mediating and transfer-
ring antibiotic resistance, we sought the presence of integrons 
in all the IncF plasmids sequenced [50–52]. Examination of 
the IncF plasmid sequences using the program IntegronFinder 
[41] revealed the presence of the Class I integron discussed 
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Fig. 1. Phylogenetic tree of plasmid isolates. Maximum likelihood phylogenetic tree based on accessory gene content was constructed 
using RAxML as described in the Methods; bootstrap support values for the tree were greater than 80 %. The tables to the right show 
antibiotic resistance genes, toxin- antitoxin pairs within the plasmids, and the Inc grouping of each plasmid, based on the database used 
with PlasmidFinder [38]. IncF groups are coloured red, col type blue and others as green. The resistance determinants were found using 
ARIBA and the CARD database.
Fig. 2. Homology between the IncF Plasmids. The phylogenetic tree of the plasmids is shown to the left. An additional non- IncF plasmid 
that is closely related is included (ECO_56_C5); only the integron cassettes are shown for this plasmid. The panels to the right show: (a) 
the outline genetic map of each plasmid with areas of homology between each successive plasmid shaded; the degree of homology is 
graded as shown by the key; (b) and (c) the identified integron (b) and CALIN (c) cassette elements. The integron recombination sites attI 
and attC are as shown.
above containing the genes dfrA7 and aadA4 downstream 
of the intI gene, together with the conserved sulI and qacEΔ 
elements of the class I integron [53] in 15 of the IncF plasmids 
(Fig. 2b).
We also found clusters of attC sites lacking integron- integrases, 
so- called CALIN elements [41], both within some of the IncF 
plasmids and in two strains, within the chromosome (Fig. 2c). 
These all contained the antibiotic resistance genes blaOXA-1 and 
10
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Fig. 3. Comparison of 5 IncF Plasmids with p1ESCUM. The indicated plasmids are shown relative to the reference plasmid p1ESCUM. The 
insertions into the p1ESCUM backbone are highlighted, with genes and mobile elements as shown.
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Aac6- Ib, encoding a beta- lactamase and an aminoglycoside 
modification enzyme respectively. These genes were tightly 
linked to the extended spectrum beta lactamase, blaCTX- M15, 
and are considered in more detail below.
Relationship of Plasmids to p1ESCum
The five plasmids with greatest overall homology (ECO_73_
C3, EC1_36_C2, EC1_5_C2 (all from ST69) and ECO_42_C2 
and EC1_77_C2 (both ST131)) were analysed in greater 
detail. Homology search of these related plasmids using 
blast identified high homology with an E.coli plasmid 
p1ESCUM in strain UMN026 (ST69), isolated in 1999 from 
a woman with uncomplicated acute cystitis in 1999 in the 
USA. The percentage identity and coverage are shown in 
Table S3. Detailed comparison of these plasmids is shown 
in Fig. 3. Sequences encoding the replicon, type IV conjugal 
transfer functions and other plasmid backbone features are 
highly conserved between the different plasmids. p1ESCUM 
contains very few antibiotic resistance genes. However, the 
homologous IncF plasmids contain a variety of insertions into 
the p1ESCUM backbone that contain a variety of antibiotic 
resistance genes. All the plasmids contain insertions of a Class 
I integron containing the genes dfrA7 and aadA4, mediating 
resistance to trimethoprim and streptomycin/spectinomycin 
respectively [54, 55]. This integron has been found in the 
IncF plasmid pEK499 from an ST131 E. coli [56] and a closely 
related dfrA17- aadA5 cassette has been described in a collec-
tion of uropathogenic E. coli isolated form urine samples of 
college students in the USA [57]. The ARG- ANNOT data 
base groups the highly similar dfrA17 and dfrA7 together, 
with a designation dfrA7. This resistance determinant was 
found in 28 % of the total 162 Scottish genomes analysed. It 
was more prevalent in the ST131 and ST69 strains, at 69 and 
50 % respectively, in both cases a significant difference from 
the total population (two sample z test, P<0.001 and<0.05 
respectively) . In addition, all the plasmids contain the 
linked sulII/strA/strB/ gene cassette, mediating resistance 
to sulphonamides and streptomycin. This cassette is wide-
spread in mobile genetic elements of a variety of bacteria [58]. 
Finally, it is notable that all the plasmids contain inserted 
sequences containing elements of the mer operon, a genetic 
system that encodes proteins responsible for detoxification of 
Hg++ and organomercury compounds to the relatively harm-
less and volatile Hg0 [59, 60]. The relevance of these genes is 
considered further in the discussion. These different inserted 
elements are present on a variety of known mobile elements, 
including transposon TnAs3, initially described in a plasmid 
of Aeromonas salmonicida [61] and also described in plasmids 
mediating broad antibiotic resistance in strains of Klebsiella 
pneumoniae [62].
Distribution of p1ESCum elements and IncF 
Plasmid Resistance Genes in Global ST69 E. coli 
Isolates
p1ESCUM was isolated from a ST69 E.coli strain as were three 
of the plasmids described above which showed high homology 
to this plasmid. We wished to determine how widespread this 
plasmid and derivatives might be in a wider sample of ST69 
isolates from different geographical areas, to determine if such 
homology was also found more widely than strains analysed 
in our local collection. Long- reads are not available for the 
vast majority of sequenced bacterial strains, so we were not 
able to reconstitute complete plasmid sequences. However, we 
interrogated sequences from 328 ST69 isolates from different 
geographical areas for the presence of different segments of 
p1ESCUM and the three resistance gene cassettes identi-
fied in plasmids ECO_73_C3, EC1_36_C2, EC1_5_C2 and 
ECO_42_C2 described above (Table S1,Fig. 4). Conservation 
of the indicated elements does not imply they are in the orig-
inal p1ESCUM backbone (or indeed necessarily all together 
in the same plasmid), as gene rearrangements will lead to 
reassortment of these sequences into other genetic locations. 
However, the observed distribution shows widespread pres-
ence of homologues of p1ESCUM elements in this collection 
of ST69 isolates, but not in all. The three resistance cassettes 
identified above had a more restricted distribution, with clear 
phylogenetic grouping (Fig. 4). Flux of these elements into or 
out of these strains has thus occurred on multiple occasions.
Distribution of CTX-m15 and oXA-1 within IncF 
Plasmids and Chromosomes
Seven of the 16 strains fully sequenced contained the blaCTX-
 M-15 encoding an extended spectrum beta- lactamase (Table 2). 
In two cases this was present in a plasmid, while it was in 
the chromosome in the remaining five. A number of other 
antibiotic resistance genes were tightly linked to the blaCTX-
 M-15 gene, including the blaOXA-1 and aac(6’)Ib gene contained 
on a CALIN as described above. The distribution of the 
blaCTX- M-15 and blaOXA-1 genes between plasmids and chromo-
some is shown in Table 2. Fig. 5a shows a comparison of the 
plasmid location of this element in EC0_10_C3 and in the 
chromosome of EC1_50_C1. The element is flanked by IS26 
sequences and also contains Tn3 transposase components, 
suggesting these have been important in its dissemination, 
a role previously noted for IS26 elements within ST131 E. 
coli [63, 64]. In two cases, the blaCTX- M-15 gene is located in 
the chromosome, while the blaOXA-1 gene is contained on 
a plasmid; this is shown for the ECO_76 strain in Fig. 5b. 
Insertion sequence mediated re- arrangements would appear 
to be instrumental in this rearrangement. In one case, only 
the blaOXA-1 gene is present, in plasmid EC1_25_C2; the blaCTX-
 M-15 gene is not present in either chromosome or plasmid 
(Fig. 5c). Again, insertion sequences seem to be responsible 
for these rearrangements. These data provide a genetic 
basis for the recently observed co- carriage of blaCTX- M-15 and 
blaOXA-1, mediating resistance to piperacillin/tazobactam and 
co- amoxiclav, as well as aac(6’)Ib, mediating resistance to 
amikacin and tobramycin [65]. Presence of the blaOXA-1 gene 
was associated with an increase in the MIC to co- amoxiclav 
from 8 to 16 mg l−1 and for piperacillin/tazobactam from <4 to 
8 mg l−1; neither of these shifts were significant between the 
groups, nor was association between resistance and presence 
of blaOAX-1. However, the numbers here are much smaller than 
those analysed in Livermore et al. [65]. One isolate (ECO_73) 
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Fig. 4. Comparison of Global ST69 Isolates. The UMN026 strain was used as reference genome to map the sequencing reads after 
masking out the mobile genetic regions. The variants were then identified using VarScan and recombinations were filtered by Gubbins. 
The midpoint rooted phylogenetic tree is built using RAxML. The x- axis of the tree represents the number of base substitutions along the 
length of the edges of the tree. The * in the tips of the tree indicates 11 of the 24 ST69 Scottish isolates from [31]; the others were much 
less related to the global isolates and formed an outlier group on the phylogenetic tree and were thus removed for ease of visualisation 
of the whole ST69 group . The panels to the right show the coverage of reads over p1ESCUM and the various resistance modules 
indicated to the right.
Table 2. Location of bla
CTX- M-15
 and bla
OXA-1
 genes within the indicated 
strains
Strain blaCTX- M-15 blaOXA-1
EC0_10 Plasmid: EC0_10_C3 Plasmid: EC0_10_C3
EC1_72 Plasmid: EC1_72_C4 Plasmid: EC1_72_C4
EC1_50 Chromosome Chromosome
EC0_33 Chromosome Chromosome
EC0_56 Chromosome Chromosome
EC0_76 Chromosome Plasmid: EC1_76_C3
EC1_6 Chromosome Plasmid: EC1_6_C5
EC1_25 Absent Plasmid: EC1_25_C2
without blaCTX- M-15 was resistant to cefotaxime, presumably 
through upregulation of chromosomal blaAMP- C. One isolate 
(ECO_76) with chromosomal blaCTX- M-15 was sensitive to 
cefotaxime; there were no sequence alterations in the coding 
sequence, so this most probably reflects low expression.
The relocation of plasmid- borne antibiotic resistance markers 
such as blaCTX- M-15 to the chromosome exemplifies aspects of 
‘chromosomal imperialism’. Strong evolutionary pressure 
against plasmid carriage under conditions where plasmid 
borne genes are not providing benefit to the host will favour 
chromosomal relocation of potentially advantageous deter-
minants such as genes encoding antibiotic resistance [24, 66]. 
Thus, survival of plasmids depends strongly on their ability 
to spread through conjugation [66]. Ten of the 16 IncF plas-
mids have a conserved specialised type IV secretion apparatus 
allowing them to be self- transmissible (Fig. S2), supporting 
the importance of conjugation in plasmid retention in bacte-
rial populations. However, synthesis of the specialised type 
IV secretion system places a fitness burden on the host, as 
well as allowing phage predation. Experimental studies have 
shown that large plasmids eliminate segments encoding the 
type IV secretion machinery under conditions of continued 
growth [67], although removing self- transmissibility and thus 
potentially consigning such plasmids to an evolutionary dead 
end. Six of the IncF plasmids sequenced here have lost the 
gene sequences responsible for synthesis of the conjugative 
apparatus (Fig. S2), suggesting such loss of this portion of 
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Fig. 5. Plasmid and chromosomal positions of bla
CTX- M-15
 and bla
OXA-1
. (a) shows locations in indicated plasmid and chromosome. Genes 
and mobile elements are highlighted. The blue block designates the element containing the bla
OXA-1
 and aac(6’)ib- cr gene. (b) shows 
location of bla
OXA-1
 in chromosome and bla
OXA-1
 in plasmid. (c) shows location of bla
OXA-1
 alone in plasmid.
a plasmid is not uncommon in naturally occurring plasmid 
populations. Five of these six plasmids are the only IncF 
plasmid within their host strain, rendering them unable 
to spread by conjugation. One plasmid lacking the genes 
encoding the conjugative apparatus, EC1_72_C4, co- exists 
in its host with another IncF plasmid, EC1_72_C5 which 
does contain these genes, potentially allowing donation of 
transmissibility to the EC1_72_C4 plasmid. To test this, we 
carried out conjugation assays from the parent strains EC1_72 
and ECO_10 (lacking a conjugation apparatus) to a recipient 
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Fig. 6. Conjugation efficiency of plasmids. Graph shows the number 
of transconjugants per donor of transfer from the indicated strains. 
Columns are means of three determinations; standard error of the 
means were <0.01 % and are too small to show on the plot. The antibiotic 
used to select transconjugants is shown next to the strain used: AMP 
is ampicillin, CTX is cefotaxime. The lower limit of detection was 10−8 
transconjugants per donor cell.
E. coli strain, DH10B (Fig. 6). As predicted, conjugal transfer 
of cefotaxime resistance mediated by the blaCTX- M-15 gene was 
successful at high frequency from the EC1_72 strain but 
below the limit of detectability for the ECO_10 strain.
Evolutionary History of Plasmids within their Host
In order better to understand the origins of the different 
plasmids studied here, we wished to estimate how long they 
had been established in their respective hosts. Over time, 
‘foreign’ DNA in a bacterium adopts a very similar compo-
sition to its host, a process known as genome amelioration 
[68]. We calculated the degree of similarity of the dinucleo-
tide frequencies between each plasmid and its bacterial host 
using the Mahalanobis distance, as described in the Methods 
[46]. Empirical probability values for the different plasmids 
sequenced in the current study is shown in Fig. S3; as outlined 
in the Methods, identity between plasmid and chromosome 
composition would have a p value approaching one. As a 
reference, we also included two E. coli O157 strains (EDL933 
and O157:H7 Sakai) that carry the pO157 plasmid, previously 
included in a study of the relationship between Mahalanobis 
value and plasmid/chromosome similarity [46]. As has 
been noted previously [46], there was a significant positive 
correlation between plasmid length and p value, such that 
the set of small col- origin plasmids were least like their host 
chromosome, and the bigger IncF plasmids most like their 
host chromosome. This suggests that the IncF plasmids are 
likely long- term residents of their hosts, while the smaller 
col plasmids may be shorter- term residents, potentially colo-
nising a variety of different bacterial hosts. This would need 
to be verified using a larger set of complete plasmid sequences 
and their corresponding chromosomes.
DISCuSSIon
The results presented here provide a comprehensive analysis of 
the plasmids contained within a group of clinical bloodstream 
isolates of E. coli and associated antibiotic resistance genes. 
Genes conferring antibiotic resistance were almost exclusively 
located on IncF group plasmids found in all of the isolates, 
while there were also large numbers of cryptic small plasmids 
of the col incompatibility group. The IncF plasmids described 
here thus play a key role in mediating antibiotic resistance 
in the clinical bloodstream isolates of E. coli used in this 
study. Plasmids require a bacterial host for their continued 
existence but their existence within bacterial cells potentially 
places a fitness burden on their host, as significant metabolic 
activity must be expended for their replication. They have 
thus evolved mechanisms to resist elimination, such as: toxin/
antitoxin pairs to avoid post- segregational loss; possession of 
genes that confer resistance to environmental stresses such as 
antibiotics or heavy metals; and the ability to transfer them-
selves to other hosts. However, blocks to segregational loss 
are not 100 % effective; resistance genes will only be selected 
in the face of constant environmental pressure; and conju-
gation rates do not appear high enough to ensure plasmid 
survival. Taken together, these blocks have not been thought 
to be sufficient to explain plasmid persistence, the so- called 
‘plasmid paradox’ [69].
Antibiotic resistance will ensure bacterial and hence plasmid 
survival if the relevant resistance gene is carried on the 
plasmid. However, movement of the gene to the chromosome 
will retain the selective advantage of resistance but remove 
the fitness cost of replicating a large plasmid. The gene for 
the extended spectrum β-lactamase CTX- M-15 was found 
in seven of the 16 isolates studied here, but only in two of 
these was it contained within a plasmid; the rest were found 
in the chromosome. This is in keeping with the postulated 
evolutionary pressure for plasmid- borne selectable markers 
to move to the chromosome. Other genes mediating antibiotic 
resistance show a similar pattern of spread to the chromo-
some – the blaOXA-1-aac6- 1b cassette carried on CALIN has 
moved to a chromosomal location in two of the strains. Other 
determinants, however, are only found on plasmids such as 
the integron cassette with the dfrA7 and aad4 genes. While 
the selective advantage of antibiotic resistance genes is clear, 
at least for areas of high usage such as hospitals, it is not 
clear why there has been retention of the mer operon within 
plasmids that mediates resistance to mercury salts. Mercuric 
compounds were used extensively in agriculture up to the 
1970s, which may have provided a selective advantage for 
these genes originally for environmental survival of bacteria 
carrying mer- containing plasmids [70, 71]. What selective 
advantage they now mediate is less clear. One possible expla-
nation for their retention is their co- selection with closely 
linked genetic elements such as antibiotic resistance genes 
that confer benefit – such as blaCTX- M-15 and blaOXA-1. This may 
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also explain the persistence of the sulII/strA/strB/ cassette 
mediating resistance to sulphonamides and streptomycin. 
Although used extensively in the past, these antibiotic are 
not used to any great degree currently; again, co- selection 
with linked genes such as dfrA7 mediating trimethoprim 
resistance may play an important role; trimethoprim is used 
extensively and remains the first- line drug for treatment of 
uncomplicated urinary tract infections within Scotland. Such 
co- selection also calls into question the perceived advantages 
of narrow spectrum antibiotic prescribing, in order to reduce 
selection for broad spectrum antibiotics. For many of the 
plasmids described here, use of trimethoprim would confer 
a selection advantage to dfrA7 containing plasmids that also 
mediate resistance to extended spectrum β-lactamases, thus 
inadvertently selecting for these resistances in addition. 
Importantly, we have also shown close genetic linkage between 
blaCTX- M-15 and blaOXA-1, explaining the recently observed asso-
ciation between these two determinants, resulting in extended 
spectrum β-lactamase activity being associated with resist-
ance to co- amoxiclav and reduced sensitivity to piperacillin/
tazobactam [65].
The universal presence of IncF plasmids within the 16 isolates 
described here and in the majority of the 162 isolates previ-
ously analysed [31] shows these plasmids are successfully 
maintained within this population of E. coli. The ability to 
spread by horizontal gene transfer is another key factor in 
their survival. Ten of the 16 IncF plasmids have a special-
ized type IV secretion apparatus that can mediate conjuga-
tive spread; one blaCTX- M-15 containing plasmid without this 
apparatus was successfully transferred by donation from a 
co- resident self- transmissible plasmid. However, five of the 
IncF plasmids are not self- transmissible and do not co- exist 
with a donor plasmid. Long term survival of these plasmids 
would thus be predicted to be doomed. In addition, these 
plasmids typically contain more than one IncF replicon, thus 
preventing uptake of any additional plasmid containing these 
replicons. Co- evolution of plasmid and host has been shown 
to ameliorate the negative fitness of plasmid carriage [72], 
and might contribute to these plasmids survival. Movement 
of plasmids into new fitter hosts that ‘sweep’ through a bacte-
rial population has also been proposed as a mechanism for 
continue bacterial survival [66], although this would not be 
possible for plasmid/host combinations that lack the ability 
for transfer by conjugation.
In order to better understand how such plasmids bearing 
antibiotic resistance might spread, we attempted to deter-
mine how long they had been present in their hosts and the 
degree to which they had spread within bacterial populations. 
Strong homology of three of the IncF plasmids within ST69 
strains to the plasmid p1ESCUM allowed us to interrogate a 
range of available ST69 sequences for the presence of similar 
elements. Although long- reads are not available for most of 
these sequences, and hence exact plasmid sequences are not 
known, we were able to demonstrate widespread possession 
of p1ESCUM elements within the ST69 lineage, with the anti-
biotic and mercury resistance elements we identified having 
a more limited distribution related to phylogenetic origin. 
This suggests strongly that this plasmid family has been 
present over significant periods of time and elements have 
been gained and lost in different sectors of the ST69 lineage. 
Analysis of the nucleotide similarity between host chromo-
some and IncF plasmids using the Mahalanobis distance 
also supports the view that the IncF plasmids are long term 
hosts of E. coli and have not been gained more recently from 
another bacterial species.
In conclusion, the ability to combine long and short whole 
genome sequencing reads allows fast and accurate reconstruc-
tion of the total plasmid population of bacterial isolates from 
bloodstream isolates. This has allowed a detailed analysis 
of the important antibiotic resistance elements present 
within plasmid and chromosome and how they are spread 
and retained. The close genetic linkage of many resistance 
elements has important clinical implications, as co- selection 
of resistances will occur even when using a narrow spectrum 
antibiotic, thus rendering antibiotic governance strategies 
impotent against the spread of resistance to agents such as 
third generation cephalosporins.
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